Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
效应器检查点 TcR 信号强度对保护性 CD4 T 细胞对流感病毒免疫的影响
基本信息
- 批准号:10027026
- 负责人:
- 金额:$ 25.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-09 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAffinityAntibodiesAntibody FormationAntigen PresentationAntigensAntiviral AgentsAttenuatedAutomobile DrivingAvidityB-LymphocytesCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCapsid ProteinsCellsCessation of lifeChildhoodCore ProteinDevelopmentDiseaseDisease OutbreaksDoseElderlyEnsureEpitopesFormulationGene Expression ProfileGenerationsImmunityIndividualInfectionInfluenzaInfluenza A virusInterleukin-2LearningLifeLongevityLungMediatingMembrane GlycoproteinsMemoryMemory B-LymphocyteMusMutateOilsPathway interactionsPeptidesPhasePhenotypePhysiologicalRecombinantsRoleSafetySignal TransductionSiteStructure of germinal center of lymph nodeSymptomsT cell responseT memory cellT-LymphocyteTissuesTransgenic OrganismsVaccinationVaccine DesignVaccinesVariantVirusWateragedautocrinebasecell injurycytokinecytotoxicdensityfirst responderimprovedin vivoinfluenza outbreakinfluenza virus vaccineinfluenzavirusinsightmemory CD4 T lymphocyteneutralizing antibodypandemic diseasepathogenpreventrepairedresponsevaccine delivery
项目摘要
SUMMARY
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza
Virus.
Our recent studies show that the development of CD4 memory requires CD4 effectors to again recognize antigen
from influenza virus in order to differentiate to memory. Many non-live vaccines, optimized for safety, induce
strong antigen presentation only for a few days and they fail to induce robust CD4 T cell memory or long-lived B
cell responses, dependent on CD4 helper effectors. Preliminary results indicate high doses of Ag are needed.
We propose to determine the impact of CD4 signal strength, both dose and affinity for the TcR, on the quantity
and quality of CD4 memory and on CD4 effectors specialized for helping B cells. We will determine whether the
CD4 memory obtained is protective and whether providing high signal strength in responses to vaccine can
improve their ability to induce CD4 memory and helper effectors. If high dose and affinity are indeed needed at
the effector stage for protective responses, vaccine strategies would need to be altered to ensure the signals
needed are provided.
总结
效应物检查点TcR信号强度对保护性CD4 T细胞抗流感免疫的影响
病毒
我们最近的研究表明,CD4记忆的形成需要CD4效应子重新识别抗原
从流感病毒中分离出来,以分化为记忆。许多针对安全性进行了优化的非活疫苗,
强的抗原呈递仅持续几天,并且它们不能诱导强的CD4 T细胞记忆或长寿命的B
细胞反应,依赖于CD4辅助效应。初步结果表明,需要高剂量的Ag。
我们建议确定CD4信号强度的影响,包括剂量和对TcR的亲和力,
和CD4记忆的质量以及专门帮助B细胞的CD4效应器。我们将决定是否
获得的CD4记忆是保护性的,是否在对疫苗的反应中提供高信号强度可以
提高其诱导CD4记忆和辅助效应物的能力。如果确实需要高剂量和亲和力,
保护性反应的效应阶段,疫苗策略需要改变,以确保信号
需要提供。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN L SWAIN其他文献
SUSAN L SWAIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN L SWAIN', 18)}}的其他基金
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
利用与年龄相关的 B 细胞开发针对老年人的通用流感疫苗
- 批准号:
10573680 - 财政年份:2022
- 资助金额:
$ 25.13万 - 项目类别:
Age-Associated B Cells Specialized for Immunity to Pathogens?
与年龄相关的 B 细胞专门针对病原体具有免疫能力?
- 批准号:
10218497 - 财政年份:2021
- 资助金额:
$ 25.13万 - 项目类别:
Age-Associated B Cells Specialized for Immunity to Pathogens?
与年龄相关的 B 细胞专门针对病原体具有免疫能力?
- 批准号:
10401919 - 财政年份:2021
- 资助金额:
$ 25.13万 - 项目类别:
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
效应器检查点 TcR 信号强度对保护性 CD4 T 细胞对流感病毒免疫的影响
- 批准号:
10187518 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Maintaining Robust T Cell Immunity For Broad Protection Against Influenza
维持强大的 T 细胞免疫力以广泛预防流感
- 批准号:
9806329 - 财政年份:2019
- 资助金额:
$ 25.13万 - 项目类别:
VACCINE STRATEGIES TO CIRCUMVENT AGE-ASSOCIATED IMMUNE DEFECTS
规避年龄相关免疫缺陷的疫苗策略
- 批准号:
9762805 - 财政年份:2018
- 资助金额:
$ 25.13万 - 项目类别:
Defining a memory checkpoint for CD4 T cells
定义 CD4 T 细胞的记忆检查点
- 批准号:
9064064 - 财政年份:2015
- 资助金额:
$ 25.13万 - 项目类别:
Defining a memory checkpoint for CD4 T cells
定义 CD4 T 细胞的记忆检查点
- 批准号:
8938979 - 财政年份:2015
- 资助金额:
$ 25.13万 - 项目类别:
Generation and persistence of CD4 memory subsets
CD4 内存子集的生成和持久化
- 批准号:
8316250 - 财政年份:2011
- 资助金额:
$ 25.13万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 25.13万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 25.13万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 25.13万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 25.13万 - 项目类别:














{{item.name}}会员




